The DASH Diet for Adults With Uncontrolled Asthma
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01725945 |
Recruitment Status
:
Completed
First Posted
: November 14, 2012
Last Update Posted
: September 18, 2014
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Asthma Hypertension | Behavioral: Dietary Approaches to Stop Hypertension dietary pattern | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 90 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Single (Investigator) |
Primary Purpose: | Health Services Research |
Official Title: | A Pilot Study of the DASH Diet in Not-Well-Controlled Adult Asthma |
Study Start Date : | January 2013 |
Actual Primary Completion Date : | May 2014 |
Actual Study Completion Date : | May 2014 |

Arm | Intervention/treatment |
---|---|
No Intervention: Usual Care
Usual Care
|
|
Experimental: DASH Intervention
Dietary Approaches to Stop Hypertension dietary pattern. Usual care in combination with a DASH intervention consisting of 8 group and 3 individual sessions over 3 months, followed by 3 monthly phone consultations.
|
Behavioral: Dietary Approaches to Stop Hypertension dietary pattern
The intervention will employ a series of small group and individual sessions, followed by periodic telephone contacts, to help participants make appropriate dietary changes and develop the skills to maintain these changes over the long term. The initial 3 months of intensive intervention will involve 8 group and 3 individual sessions for 45-60 minutes each. During the next 3 months, participants will receive counseling phone calls once per month for 20-30 minutes each call. Group session sizes may range from 8-15 participants.
Other Name: DASH
|
- 7-item Juniper Asthma Control Questionnaire (ACQ) [ Time Frame: 6-months post-randomizaton ]The ACQ provides a reliable, validated assessment of asthma control focusing on current impairment. Its 7 items assess the components of current asthma impairment as defined in the asthma treatment guidelines, i.e., daytime and nocturnal asthma symptoms, activity limitations, rescue medication use (excluding use to prevent exercise-induced bronchospasm), and lung function (FEV1). The ACQ is the only guideline-recommended composite measure of asthma control that includes lung function in its overall rating.
- Lung function [ Time Frame: 6-months post-randomization ]Lung function measured by spirometry
- Asthma specific Quality of Life [ Time Frame: 6-months post-randomization ]Juniper Mini Asthma Quality of Life Questionnaire (Mini-AQLQ)
- Asthma symptom-free and β2-agonist-free days [ Time Frame: 6-months post-randomization ]Asthma symptom-free and β2-agonist-free days will be calculated from 2-week asthma symptom diaries.
- Asthma-related health care utilization [ Time Frame: 6 months pre-and post-randomization ]Asthma-related health care utilization will be assessed through data extraction from Kaiser Permanente (KP) electronic databases for the periods of 6 months pre- and post-randomization
- Diet adherence [ Time Frame: 6-months post-randomization ]Participants' adherence to the DASH diet will be assessed by multiple-pass 24-hour diet recalls for servings of fruits, vegetables, dairy products, and whole grains; increases in serum carotenoids, folate and vitamin B12; and reductions in fasting plasma lipids.
- Psychosocial predictors of dietary change [ Time Frame: 6-months post-randomization ]Self-efficacy and social support for dietary change will be assessed using previously validated instruments.
- Comorbidities [ Time Frame: 6-months post-randomization ]Sleep apnea and gastroesophageal reflux disease (GERD) are common comorbidities of obesity and asthma. The Berlin Questionnaire for Sleep Apnea and the GERD Symptom Assessment Scale will be administered to screen for these conditions and to assess changes in symptoms. In addition, the Pittsburgh Sleep Quality Index will be used to assess participants' usual sleep habits and sleep quality. The 9-item Patient Health Questionnaire (PHQ-9) is both a measure of depressive symptomatology and a tentative diagnostic instrument for the Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV) depressive disorders.
- Generic health related Quality of Life [ Time Frame: 6-months post-randomization ]The 12-item Short Form Health Survey (SF-12) is a widely used measure to assess non-disease specific physical and mental health status.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 70 Years (Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Ethnicity: All ethnic groups
- Body mass index (BMI) 18.5-39.9 kg/m2
- Suboptimally controlled asthma:
- Diagnosis of asthma on the current medical problem list
- Currently prescribed at least 1 medication for the treatment of asthma
- Physiological evidence of asthma with demonstrable reversibility of airway obstruction, or a specialist's confirmation of asthma diagnosis based on chart review
- Documented history of high asthma-related emergency and/or inpatient encounters or reliever medication usage
- Asthma Control Test: total score <20 or item score <3 for any of the first 4 questions regarding symptoms (3-6x/week or more), nighttime awakening (1x/week or more), interference with normal activity (at least some of the time), and rescue medication use for symptom relief (2-3x/week or more)
- Kaiser member for ≥1 year
- PCP approval of study screening
- Able and willing to enroll and provide written informed consent
Exclusion Criteria:
- Intermittent asthma, defined as either seasonal asthma or (daytime asthma symptoms <2x/week and nocturnal symptoms <2x/month and no use of long-term control medications)
- Primary diagnosis of COPD (emphysema or chronic bronchitis) on the current medical problem list or suggested by baseline spirometry and smoking history
- Previous diabetes (other than during pregnancy) or diabetes diagnosed as a result of fasting blood glucose or hemoglobin A1c levels obtained at screening
- Previous cardiovascular disease: e.g., coronary heart disease, cerebrovascular disease, peripheral vascular disease, heart failure, or aortic aneurysm
- Diagnosis of cancer (other than non-melanoma skin cancer) that is/was active or treated with radiation or chemotherapy within the past 2 years
- Inflammatory bowel disease, colostomy, malabsorption, or major gastrointestinal resection
- Diagnosis of bipolar or psychotic disorder or hospitalization for psychological or emotional problems within the last 2 years
- Diagnosis of a terminal illness and/or in hospice care
- Fasting LDL cholesterol >190 mg/dL, triglycerides >500 mg/dl, fasting blood glucose >125 mg/dl
- Significant liver enzyme abnormality as indicated by AST or ALT more than 2 times the upper limit of normal or a clinical diagnosis of hepatitis
- Renal insufficiency (GFR<60 ml/min)
- Current use of insulin or oral hypoglycemic agents
- Use of oral corticosteroids >5 days/month on average
- Current use of medications for treatment of psychosis or manic-depressive illness
- Current use of prescription or non-prescription weight-loss products or any dietary/herbal supplements and unwillingness to discontinue;
- Inability to speak, read, or understand English at the 6th-grade level or above
- Inability to perform pulmonary function tests by spirometry in a consistent manner
- DASH concordance index >60%
- Unwillingness to modify current diet
- Current or planned participation in a structured program that overtly focuses on diet and nutrition
- Planning to undergo bariatric surgery during the study period
- Actively attempting to lose weight, or weight change >15 lbs during prior 3 months
- Consumption of >21 alcoholic drinks per week, or >=6 drinks on one occasion twice or more per week, or alcoholism as determined by the Alcohol Use Disorders Identification Test
- Pregnant, lactating, or planning to become pregnant during the study period
- No longer a Kaiser patient or planning to transfer care out of Kaiser or to move out of the area during the study period
- Family/household member of another study participant or of a study staff member
- Enrolled or planning to enroll in another research study that would limit full participation in the study or confound the interpretation of the study's findings
- Investigator discretion for safety or protocol adherence reasons

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01725945
United States, California | |
Kaiser Permanente, Hayward Medical Center, Allergy Department | |
Hayward, California, United States, 94545 | |
Kaiser Permanente, San Francisco Medical Center, Allergy Department | |
San Francisco, California, United States, 94115 |
Principal Investigator: | Jun Ma, MD, PhD | Palo Alto Medical Foundation |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: | Jun Ma, MD, PhD, Associate Investigator, Palo Alto Medical Foundation |
ClinicalTrials.gov Identifier: | NCT01725945 History of Changes |
Other Study ID Numbers: |
R34HL108753 ( U.S. NIH Grant/Contract ) |
First Posted: | November 14, 2012 Key Record Dates |
Last Update Posted: | September 18, 2014 |
Last Verified: | September 2014 |
Keywords provided by Jun Ma, MD, PhD, Palo Alto Medical Foundation:
DASH diet asthma adults asthma control |
Additional relevant MeSH terms:
Asthma Bronchial Diseases Respiratory Tract Diseases Lung Diseases, Obstructive Lung Diseases |
Respiratory Hypersensitivity Hypersensitivity, Immediate Hypersensitivity Immune System Diseases |